Overview
Efficacy and Safety of Dianicline Versus Placebo as an Aid to Smoking Cessation
Status:
Completed
Completed
Trial end date:
2007-06-01
2007-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The primary objective is to demonstrate the efficacy of dianicline as an aid to smoking cessation in cigarette smokers. The main secondary objectives are: to assess the craving for cigarettes, nicotine withdrawal symptoms and the safety of dianicline.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Sanofi
Criteria
Inclusion Criteria:- Outpatients over the legal age smoking at least 10 cigarettes per day for at least 2
months
Exclusion Criteria:
- Insufficient level of motivation
- Another participant in the household
- Patients with current psychotic disorder or major depressive disorder
The investigator will evaluate whether there are other reasons why a patient may not
participate.